130 related articles for article (PubMed ID: 11895445)
41. The pro region N-terminal domain provides specific interactions required for catalysis of alpha-lytic protease folding.
Cunningham EL; Mau T; Truhlar SM; Agard DA
Biochemistry; 2002 Jul; 41(28):8860-7. PubMed ID: 12102628
[TBL] [Abstract][Full Text] [Related]
42. Regulation of signal peptidase by phospholipids in membrane: characterization of phospholipid bilayer incorporated Escherichia coli signal peptidase.
Wang Y; Bruckner R; Stein RL
Biochemistry; 2004 Jan; 43(1):265-70. PubMed ID: 14705954
[TBL] [Abstract][Full Text] [Related]
43. Wash-Free Amperometric
Park S; Park K; Cho H; Kwon J; Kim KS; Yang H
Anal Chem; 2022 Mar; 94(11):4756-4762. PubMed ID: 35143182
[TBL] [Abstract][Full Text] [Related]
44. Enterohemorrhagic Escherichia coli OmpT regulates outer membrane vesicle biogenesis.
Premjani V; Tilley D; Gruenheid S; Le Moual H; Samis JA
FEMS Microbiol Lett; 2014 Jun; 355(2):185-92. PubMed ID: 24813639
[TBL] [Abstract][Full Text] [Related]
45. Mutation and Suppressor Analysis of the Essential Lipopolysaccharide Transport Protein LptA Reveals Strategies To Overcome Severe Outer Membrane Permeability Defects in Escherichia coli.
Falchi FA; Maccagni EA; Puccio S; Peano C; De Castro C; Palmigiano A; Garozzo D; Martorana AM; Polissi A; Dehò G; Sperandeo P
J Bacteriol; 2018 Jan; 200(2):. PubMed ID: 29109183
[TBL] [Abstract][Full Text] [Related]
46. MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex.
Coats SR; Pham TT; Bainbridge BW; Reife RA; Darveau RP
J Immunol; 2005 Oct; 175(7):4490-8. PubMed ID: 16177092
[TBL] [Abstract][Full Text] [Related]
47. Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase.
Komazin G; Maybin M; Woodard RW; Scior T; Schwudke D; Schombel U; Gisch N; Mamat U; Meredith TC
J Biol Chem; 2019 Dec; 294(50):19405-19423. PubMed ID: 31704704
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of alpha-lytic protease by pro region C-terminal steric occlusion of the active site.
Sohl JL; Shiau AK; Rader SD; Wilk BJ; Agard DA
Biochemistry; 1997 Apr; 36(13):3894-902. PubMed ID: 9092819
[TBL] [Abstract][Full Text] [Related]
49. Keratinocyte growth factor-2 production in an ompT-deficient Escherichia coli K-12 mutant.
Laird MW; Cope K; Atkinson R; Donahoe M; Johnson K; Melick M
Biotechnol Prog; 2004; 20(1):44-50. PubMed ID: 14763822
[TBL] [Abstract][Full Text] [Related]
50. Correlation of an adenine-specific conformational change with the ATP-dependent peptidase activity of Escherichia coli Lon.
Patterson J; Vineyard D; Thomas-Wohlever J; Behshad R; Burke M; Lee I
Biochemistry; 2004 Jun; 43(23):7432-42. PubMed ID: 15182186
[TBL] [Abstract][Full Text] [Related]
51. New outer membrane-associated protease of Escherichia coli K-12.
Kaufmann A; Stierhof YD; Henning U
J Bacteriol; 1994 Jan; 176(2):359-67. PubMed ID: 8288530
[TBL] [Abstract][Full Text] [Related]
52. Escherichia coli outer membrane protease OmpT confers resistance to urinary cationic peptides.
Hui CY; Guo Y; He QS; Peng L; Wu SC; Cao H; Huang SH
Microbiol Immunol; 2010 Aug; 54(8):452-9. PubMed ID: 20646209
[TBL] [Abstract][Full Text] [Related]
53. Contributions of polysaccharide and lipid regions of lipopolysaccharide to the recognition by spike G protein of bacteriophage phi X174.
Kawaura T; Inagaki M; Tanaka A; Kato M; Nishikawa S; Kashimura N
Biosci Biotechnol Biochem; 2003 Apr; 67(4):869-76. PubMed ID: 12784630
[TBL] [Abstract][Full Text] [Related]
54. OmpT proteolysis of E. coli initiation factor IF2. Elimination of a cleavage site by site-directed mutagenesis.
Lassen SF; Mortensen KK; Sperling-Petersen HU
Biochem Int; 1992 Aug; 27(4):601-11. PubMed ID: 1417895
[TBL] [Abstract][Full Text] [Related]
55. Mutational evidence of transition state stabilization by serine 88 in Escherichia coli type I signal peptidase.
Carlos JL; Klenotic PA; Paetzel M; Strynadka NC; Dalbey RE
Biochemistry; 2000 Jun; 39(24):7276-83. PubMed ID: 10852727
[TBL] [Abstract][Full Text] [Related]
56. Acquisition of apparently intact and unmodified lipopolysaccharides from Escherichia coli by Bdellovibrio bacteriovorus.
Stein MA; McAllister SA; Torian BE; Diedrich DL
J Bacteriol; 1992 May; 174(9):2858-64. PubMed ID: 1373716
[TBL] [Abstract][Full Text] [Related]
57. Structure of the Escherichia coli heptosyltransferase WaaC: binary complexes with ADP and ADP-2-deoxy-2-fluoro heptose.
Grizot S; Salem M; Vongsouthi V; Durand L; Moreau F; Dohi H; Vincent S; Escaich S; Ducruix A
J Mol Biol; 2006 Oct; 363(2):383-94. PubMed ID: 16963083
[TBL] [Abstract][Full Text] [Related]
58. In vivo assembly of the tau-complex of the DNA polymerase III holoenzyme expressed from a five-gene artificial operon. Cleavage of the tau-complex to form a mixed gamma-tau-complex by the OmpT protease.
Pritchard AE; Dallmann HG; McHenry CS
J Biol Chem; 1996 Apr; 271(17):10291-8. PubMed ID: 8626597
[TBL] [Abstract][Full Text] [Related]
59. Comparison of Escherichia coli K-12 outer membrane protease OmpT and Salmonella typhimurium E protein.
Grodberg J; Dunn JJ
J Bacteriol; 1989 May; 171(5):2903-5. PubMed ID: 2651422
[TBL] [Abstract][Full Text] [Related]
60. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
Joiner KA; Goldman R; Schmetz M; Berger M; Hammer CH; Frank MM; Leive L
J Immunol; 1984 Jan; 132(1):369-75. PubMed ID: 6197449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
